Correction to: Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative‑intent Resection for Lung Cancer

Gowing, Stephen; Baker, Laura; Tran, Alexandre; Zhang, Zach; Ahn, Hilalion; Ivanovic, Jelena; Anstee, Caitlin; Grigor, Emma; Gilbert, Sébastien; Maziak, Donna E.; Shamji, Farid M.; Sundaresan, Sudhir; Villeneuve, Patrick J.; Seely, Andrew J. E.

doi:10.1007/s00408-020-00409-3

Cited by 4 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite these advancements, 4,5 approximately half of the patients still face a substantial risk of recurrence and metastasis post-surgery. 6 The increasing prevalence of health screenings and the routine use of low-dose spiral CT scans have led to more early-stage lung cancer detections. According to the 8th edition of the TNM staging system, the 5-year survival rates for stage 1A and 1B lung cancer patients are 77%-92% and 68%, respectively.…”

Section: Introductionmentioning

confidence: 99%

“…Advances in molecular targeted therapy and immunotherapy have significantly improved survival rates for NSCLC patients, particularly those with sensitive gene mutations or in advanced stages, effectively reducing metastasis and recurrence rates. Despite these advancements, 4,5 approximately half of the patients still face a substantial risk of recurrence and metastasis post‐surgery 6 …”

Section: Introductionmentioning

confidence: 99%

“…Despite these advancements, 4 , 5 approximately half of the patients still face a substantial risk of recurrence and metastasis post‐surgery. 6 …”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Investigating the determinants of fear of cancer recurrence in patients with early‐stage non‐small cell lung cancer: Insights from a restricted cubic spline model

Liu,

et al. 2024

Cancer Medicine

View full text Add to dashboard Cite

ObjectiveThis study aims to investigate the determinants and the dose–response relationship of fear of cancer recurrence among patients with early‐stage non‐small cell lung cancer (NSCLC), aiming to inform prevention and intervention strategies.MethodsEmploying a cross‐sectional design, we analyzed data from 677 postoperative NSCLC patients who received treatment at National Cancer Center between January 2022 and August 2023. Data collection involved a general demographic survey, the Fear of Progression Questionnaire‐Short Form, Hope Herth Index, and Social Support Rating Scale. We employed logistic regression and restricted cubic spline models to identify factors influencing fear of recurrence (FCR).ResultsUnivariate regression analysis identified female gender and having minor children as significant risk factors, while being older than 60, a higher income, and elevated levels of hope and social support emerged as protective factors. Multivariate logistic regression revealed age (OR = 0.392, 95% CI 0.205–0.750), monthly income (OR = 0.016, 95% CI 0.315–0.886), hope level (OR = 0.305, 95% CI 0.187–0.496), and social support (OR = 0.584, 95% CI 0.375–0.908) as independent influencers of recurrence fear. The restricted cubic spline model indicated a nonlinear impact of hope and social support on this fear.ConclusionAnalysis using the restricted cubic spline model underscores the influence of age, income, hope, and social support on FCR, with a nonlinear dose–response relationship evident between hope, social support, and fear. Prioritizing the enhancement of social support before increasing hope levels can rapidly and effectively alleviate FCR.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Investigating the determinants of fear of cancer recurrence in patients with early‐stage non‐small cell lung cancer: Insights from a restricted cubic spline model

Liu,

et al. 2024

Cancer Medicine

View full text Add to dashboard Cite

show abstract

“…Evidence supports a reduction in quality of life (QoL), prolonged hospitalisations with intense resource utilisation 2 and impaired postoperative recovery associated with AEs. 3 Furthermore, the association of earlier cancer recurrence following AEs 4 and its link to increased mortality 5 6 behove the thoracic surgeon to minimise any deviation from expected postoperative care.…”

Section: Introductionmentioning

confidence: 99%

Index hospital cost of adverse events following thoracic surgery: a systematic review of economic literature

Jones,

Kumar,

Anstee

et al. 2023

BMJ Open

Self Cite

View full text Add to dashboard Cite

ObjectivesAdverse events (AEs) following thoracic surgery place considerable strain on healthcare systems. A rigorous evaluation of the economic impact of thoracic surgical AEs remains lacking and is required to understand the value of money of formal quality improvement initiatives. Our objective was to conduct a systematic review of all available literature focused on specific cost of postoperative AEs following thoracic surgery.DesignSystematic review of the economic literature was performed, following recommendations from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.Data sourcesAn economic search filter developed by the Canadian Agency for Drugs and Technologies in Health was applied, and MEDLINE, Embase and The Cochrane Library were searched from inception to January 2022.Eligibility criteriaWe included English articles involving adult patients who underwent a thoracic surgical procedure with estimated costs of postoperative complications. Eligible study designs included comparative observational studies, randomised control trials, decision analytic or cost-prediction models, cost analyses, cost or burden of illness studies, economic evaluation studies and systematic reviews and/or meta-analyses of cost analyses and cost of illness studies.Data extraction and synthesisTwo reviewers independently screened titles and abstracts in the first stage and full-text articles of included studies in the second stage. Disagreements during abstract and full-text screening stages were resolved via discussion until a consensus was reached. Studies were appraised for methodological quality using the Critical Appraisal Skills Program checklist.Results3349 studies were identified: 20 met inclusion criteria. Most were conducted in the USA (12/20), evaluating AE impact on hospital expenditures (18/20). 68 procedure-specific AE mean costs were characterised (USD$). The most commonly described were anastomotic leak (mean:range) (USD$49 278:$6 176–$133 002) and pneumonia ($12 258:$2608–$34 591) following esophagectomy, and prolonged air leak ($2556:$571–$3573), respiratory failure ($19 062:$11 841–$37 812), empyema ($30 189:$23 784–$36 595), pneumonia ($15 362:$2542–$28 183), recurrent laryngeal nerve injury ($16 420:$4224–$28 616) and arrhythmia ($6835:$5833–$8659) following lobectomy.ConclusionsHospital costs associated with AEs following thoracic surgery are substantial and varied. Quantifying costs of AEs enable future economic evaluation studies, which could help prioritising value-directed quality improvement to optimally improve outcomes and reduce costs.

show abstract

“…Preoperative chemotherapy immunotherapy and adjuvant immunotherapy can improve the prognosis of selected resectable lung cancer patients, which makes some patients suspected of lymph node metastasis before surgery achieve a decline or can be operated on [7] . However, evidence suggests that 50% of patients after surgery still face the risk of recurrence and metastasis, bringing a heavy psychological burden to the affected individuals [8][9] .…”

Section: Introductionmentioning

confidence: 99%

A cross-sectional study on the prediction model of fear of cancer recurrence in individuals with non-small cell lung cancer

Liu

Wang

et al. 2023

Preprint

View full text Add to dashboard Cite

Objective To study the fear of cancer recurrence (FCR) of individuals with non-small cell lung cancer (NSCLC); this research focused on developing and validating a prediction model to identify which individuals with NSCLC were at high risk of relapse fear. Methods The sociodemographic and clinical variable data of 347 NSCLC patients from the Department of Thoracic Surgery, Cancer Hospital of Chinese Academy of Medical Sciences from December 2020 to September 2022 were collected by convenience sampling. The t-test, ANOVA, and nonparametric test were used to test the difference of a single factor in the disease fear scores of patients with NSCLC with different demographic characteristics and disease-related conditions. After the disease fear scores were converted into binary data (fear and no fear), the univariate logistic regression analysis was conducted according to the univariate analysis. Multivariate logistic regression analysis was conducted by adjusting the relevant covariates to establish a risk prediction model for NSCLC patients to fear disease progression. Results Gender, ethnicity, family per capita monthly income, and hope level were independent predictors of cancer recurrence fear in patients with non-small cell lung cancer. The model established by these predictors showed that the area under the curve was 0.891,95% confidence interval:0.858–0.924. Conclusion This study developed a validated and easy-to-use prediction algorithm that can be used to identify patients at high risk of recurrence fear with moderate accuracy.

show abstract

Correction to: Postoperative Adverse Events are Associated with Oncologic Recurrence Following Curative‑intent Resection for Lung Cancer

Cited by 4 publications

References 0 publications

Investigating the determinants of fear of cancer recurrence in patients with early‐stage non‐small cell lung cancer: Insights from a restricted cubic spline model

Investigating the determinants of fear of cancer recurrence in patients with early‐stage non‐small cell lung cancer: Insights from a restricted cubic spline model

Index hospital cost of adverse events following thoracic surgery: a systematic review of economic literature

A cross-sectional study on the prediction model of fear of cancer recurrence in individuals with non-small cell lung cancer

Contact Info

Product

Resources

About